Skin Activating Treatment Cream

Product Overview

Bioyona Skin Activating Treatment Cream delivers Totipotent Prostembryona Factor® (TPF) — Bioyona's proprietary bioactive extracted from deep-sea fish embryonic stem cells — in a rich cream vehicle designed for patients who require both intensive moisturisation and cellular activation therapy. While the Bioyona Skin Activating Treatment Serum provides a lightweight, rapidly-absorbed vehicle suited to pre-treatment priming and post-procedure skin, the Cream formulation is optimised for patients with dry, compromised, or barrier-disrupted skin phenotypes, including those in the recovery phase following ablative laser resurfacing, sustained isotretinoin therapy, or chronic eczematous episodes. The cream base provides an occlusive moisturising environment that reduces transepidermal water loss (TEWL), while TPF bioactives simultaneously support anti-oxidant protection, pigment control, and dermal collagen synthesis.

TPF has been characterised in controlled assays for four clinically relevant functions: anti-oxidation (scavenging reactive oxygen species), tyrosinase inhibition (reducing excess melanin production for skin brightening), collagen synthesis stimulation (supporting dermal structural integrity), and epidermal wound-healing acceleration (promoting keratinocyte migration and re-epithelialisation). The cream formulation also incorporates Sodium Hyaluronate for multi-depth hydration, Squalane or equivalent emollients for TEWL reduction, and Snow Algae Extract as an adaptive oxidative-stress bioactive. Clinical in-use testing confirms the formulation does not induce erythema, pruritus, or tingling, making it suitable for sensitive, reactive, or post-procedure skin.

Specifications

Key Applications

• Post-ablative laser, fractional resurfacing, or deep chemical peel recovery — TPF wound-healing activity and occlusive cream base support re-epithelialisation and TEWL reduction
• Intensive treatment for dry, atopic, or compromised skin barriers, where both sustained hydration and anti-oxidant cellular support are clinically warranted
• Hyperpigmentation management programmes, providing daily TPF tyrosinase inhibition alongside barrier repair, complementing prescription brightening agents
• Anti-ageing maintenance therapy targeting collagen remodelling and photoageing reversal in patients with mature or sun-damaged skin
• Post-isotretinoin or post-corticosteroid barrier restoration, where skin thinning and dryness require emollient occlusion combined with cellular regenerative support
• Medical spa maintenance cream dispensed for home use following in-clinic TPF serum treatment sessions

Frequently Asked Questions

How does the Cream differ from the Bioyona Skin Activating Treatment Serum?

Both products share the TPF bioactive technology but are formulated for different clinical roles. The Serum is a lightweight, rapidly absorbed formula suited to pre-treatment priming, in-clinic application under procedures, or post-treatment boosting on intact or recovering skin. The Cream provides additional emollient occlusion and is indicated when sustained barrier protection and TEWL reduction are clinically important — for example, in patients with dry skin phenotypes, chronic barrier disruption, or in the recovery phase after ablative resurfacing. Clinicians may prescribe both products in sequence: serum first, cream as the final occlusive layer.

Is the cream appropriate for post-laser or post-peel skin?

Yes. The cream's tolerability profile — free from irritancy induction in clinical testing — combined with TPF wound-healing activity makes it well-suited to post-procedure recovery protocols. Application should be initiated by the treating physician or aesthetic nurse once active weeping or exudation has resolved and the skin surface is intact. It should not be applied to open or blistered skin without explicit clinical instruction.

Can this cream be used as a daily moisturiser by patients at home?

The cream can be dispensed for home maintenance use under practitioner guidance, particularly as a twice-daily moisturiser for patients continuing a brightening, anti-ageing, or post-procedure skin programme initiated in-clinic. It is not formulated as a prescription drug and does not require a prescription, but its professional-grade actives are most effectively integrated when a trained aesthetic practitioner has assessed the patient's skin and established a structured treatment plan.

Is Bioyona compliant with Singapore cosmetics regulations?

Cosmetic products supplied in Singapore are governed by HSA's post-market surveillance framework under the ASEAN Cosmetic Directive, which mandates ingredient safety, accurate product labelling, and prohibited/restricted substance compliance. Bioyona products are formulated in compliance with these requirements; EMIS+ sources directly from the authorised Bioyona channel. Practitioners should retain product documentation for compliance records.

Who distributes Bioyona in Singapore?

Bioyona Skin Activating Treatment Cream is available in Singapore through EMIS+ (Essential Medical International Supplies Pte Ltd), the authorised medical aesthetic supply channel for the product range. Orders are available for professional clinic procurement with delivery islandwide.